Lectenz Bio receives NIH NIGMS SBIR Phase II

Date: September 15, 2023
Author: dschulz

To investigate the differences between reagents used to analyze N-glycans, we benchmarked our N-GlyFind™ Core-Specific Reagent against three commonly used lectins using the same 32 N-glycan array from Gao et al. (2019), allowing for a direct comparison of structural recognition across the four carbohydrate-binding proteins.

The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop the GlycoSense™ technology for monitoring glycosylation during glycoprotein production.